Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (241-250 of 1,111) with videos related to

Pageof 112
Sort By:
International Journal of Cardiology|March 28, 2003
Age and lack of beta-blocker therapy are associated with increased long-term mortality after primary coronary angioplasty for acute myocardial infarctionJean-Michel Juliard, Patrick Charlier, Jean-Louis Golmard, et al.
American Heart Journal|December 1, 2012
Design and rationale of the treatment of acute coronary syndromes with otamixaban trial: a double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non-ST-segment elevation acute coronary syndromes with a planned early invasive strategyPhilippe Gabriel Steg, Shamir R Mehta, Charles V Pollack, et al.
Journal of Hypertension|November 10, 2017
External validation and comparison of formulae estimating 24-h sodium intake from a fasting morning urine sampleEmmanuelle Vidal-Petiot, Adrien Joseph, Matthieu Resche-Rigon, et al.
European Heart Journal|March 15, 2014
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent typeEdoardo Camenzind, Eric Boersma, William Wijns, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 31, 2011
Two-year vascular event rates in patients with symptomatic cerebrovascular disease: the REACH registryNarayanaswamy Venketasubramanian, Joachim Röther, Deepak L Bhatt, et al.
Heart (British Cardiac Society)|September 2, 2011
Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugsLamiae Grimaldi-Bensouda, Michel Rossignol, Nicolas Danchin, et al.
Journal of Vascular Surgery|July 22, 2008
Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) RegistryIris Baumgartner, Alan T Hirsch, Maria Teresa B Abola, et al.
International Journal of Cardiology|March 22, 2017
Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysisAlexander C Fanaroff, Vic Hasselblad, Matthew T Roe, et al.
Chest|July 9, 2005
B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspneaPhilippe Gabriel Steg, Laurence Joubin, James McCord, et al.
Stroke|June 27, 2013
Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials"Stefan K James, Robert F Storey, Karen S Pieper, et al.
Pageof 112

Showing results (241-250 of 1,111) with videos related to

Sort By:
Pageof 112
International Journal of Cardiology|March 28, 2003
Age and lack of beta-blocker therapy are associated with increased long-term mortality after primary coronary angioplasty for acute myocardial infarctionJean-Michel Juliard, Patrick Charlier, Jean-Louis Golmard, et al.
American Heart Journal|December 1, 2012
Design and rationale of the treatment of acute coronary syndromes with otamixaban trial: a double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non-ST-segment elevation acute coronary syndromes with a planned early invasive strategyPhilippe Gabriel Steg, Shamir R Mehta, Charles V Pollack, et al.
Journal of Hypertension|November 10, 2017
External validation and comparison of formulae estimating 24-h sodium intake from a fasting morning urine sampleEmmanuelle Vidal-Petiot, Adrien Joseph, Matthieu Resche-Rigon, et al.
European Heart Journal|March 15, 2014
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent typeEdoardo Camenzind, Eric Boersma, William Wijns, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 31, 2011
Two-year vascular event rates in patients with symptomatic cerebrovascular disease: the REACH registryNarayanaswamy Venketasubramanian, Joachim Röther, Deepak L Bhatt, et al.
Heart (British Cardiac Society)|September 2, 2011
Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugsLamiae Grimaldi-Bensouda, Michel Rossignol, Nicolas Danchin, et al.
Journal of Vascular Surgery|July 22, 2008
Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) RegistryIris Baumgartner, Alan T Hirsch, Maria Teresa B Abola, et al.
International Journal of Cardiology|March 22, 2017
Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysisAlexander C Fanaroff, Vic Hasselblad, Matthew T Roe, et al.
Chest|July 9, 2005
B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspneaPhilippe Gabriel Steg, Laurence Joubin, James McCord, et al.
Stroke|June 27, 2013
Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials"Stefan K James, Robert F Storey, Karen S Pieper, et al.
Pageof 112